Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.24 Analyst target: $7.71 Upside: 137.96%
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. The company is headquartered in Morristown, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.